TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3664426

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) 10 mg to 20 mg twice orally
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (NAN) 50 mg every second week or 100 mg every third week intramuscularly
Number of subjects: 127

Group type: COMPARATOR
Intervention: Tamoxifen (TAM)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Nandrolone decanoate (NAN)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate (NAN) after Tamoxifen (TAM)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Tamoxifen (TAM) after Nandrolone decanoate (NAN)
Number of subjects: 127
Study: 29220121

Group type: EXPERIMENTAL
Intervention: 10 kHz spinal cord stimulation (SCS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1 kHz spinal cord stimulation (SCS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4 kHz spinal cord stimulation (SCS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 7 kHz spinal cord stimulation (SCS)
Number of subjects: 0
Study: 28303726

Group type: EXPERIMENTAL
Intervention: Jet injection of insulin aspart (0.2 units/kg body weight)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional pen administration of insulin aspart (0.2 units/kg body weight)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Jet injection of insulin aspart
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional pen administration of insulin aspart
Number of subjects: 30
Study: 26208795

Group type: EXPERIMENTAL
Intervention: ezetimibe 10 mg/day
Number of subjects: 51

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 51
Study: 22695016

Group type: EXPERIMENTAL
Intervention: Computer-aided surgical simulation (CASS) protocol with chin template
Number of subjects: 65

Group type: COMPARATOR
Intervention: Computer-aided surgical simulation (CASS) protocol without chin template
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Computer-aided surgical simulation (CASS) protocol
Number of subjects: 65
Study: 21946803

Group type: EXPERIMENTAL
Intervention: Telephone-delivered collaborative care intervention
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Components of collaborative care
Number of subjects: 150
Study: 18781134

Group type: EXPERIMENTAL
Intervention: Vindesine treatment for 2 years
Number of subjects: 142

Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Vindesine treatment
Number of subjects: 142
Study: 16958010

Group type: EXPERIMENTAL
Intervention: Virtual endoscopy (VE) simulation
Number of subjects: 13
Study: 12944243

Group type: EXPERIMENTAL
Intervention: Milrinone 50 microg/kg plus 0.5 microg/kg/min for 10 hours
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Amrinone 1.5 mg/kg plus 10 microg/kg/min infusion for 10 hours
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Milrinone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Amrinone
Number of subjects: 45
Study: 10651749

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 13
Study: 7495244

Group type: EXPERIMENTAL
Intervention: Beta-carotene 50 mg/d and retinol 25,000 IU/d on alternate days
Number of subjects: 755

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 755
Study: 2183940

Group type: EXPERIMENTAL
Intervention: Ceftazidime with metronidazole
Number of subjects: 100

Group type: COMPARATOR
Intervention: Netilmicin with metronidazole
Number of subjects: 100
Study: 536838

Group type: EXPERIMENTAL
Intervention: Tc‐99m antimony sulfide
Number of subjects: 46

Group type: COMPARATOR
Intervention: Tc‐99m stannous phytate
Number of subjects: 46
Study: 30938681

Group type: EXPERIMENTAL
Intervention: SmartLink app (intervention arm)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Standard of care (control arm)
Number of subjects: 345
Study: 28168381

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg bolus and 2 mg/kg/h continuous infusion during the operation)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 52
Study: 25447615

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 0
Study: 23461581

Group type: EXPERIMENTAL
Intervention: Intrathecal immunoglobulin (1000 IU, free of preservatives) plus intramuscular immunoglobulin (3000 IU)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intramuscular immunoglobulin (3000 IU, with preservative)
Number of subjects: 120
Study: 21565663

Group type: EXPERIMENTAL
Intervention: Corrective statements (text-based and pictorial)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: DOJ, Interveners, and emotive statements
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Emotive statement
Number of subjects: 239
Study: 19760991

Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitor (PPI) Group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Truncal Vagotomy Group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Liquid diet
Number of subjects: 50
Study: 16572922

Group type: EXPERIMENTAL
Intervention: Alendronate 70 mg tablet formulation
Number of subjects: 80
Study: 12611838

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Parenting education control program
Number of subjects: 50
Study: 10831943

Group type: EXPERIMENTAL
Intervention: Phytoestrogens (PE) 80 mg/day of isoflavones
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9205015

Group type: EXPERIMENTAL
Intervention: Dipyridamole hyperemia
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Normal myocardium subtended by bypass grafts
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saphenous vein grafts
Number of subjects: 25

Group type: COMPARATOR
Intervention: Internal mammary artery grafts
Number of subjects: 25

Group type: COMPARATOR
Intervention: Venous grafts
Number of subjects: 25

Group type: COMPARATOR
Intervention: Arterial grafts
Number of subjects: 25
Study: 8221449

Group type: EXPERIMENTAL
Intervention: PRP‐T vaccine mixed with DPT vaccine (combined in one injection)
Number of subjects: 433

Group type: COMPARATOR
Intervention: PRP‐T vaccine given as separate, bilateral injections
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Both treatment groups (PRP‐T and DPT vaccines)
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: PRP‐T vaccine mixed with DPT vaccine
Number of subjects: 433
Study: 3112713

Group type: EXPERIMENTAL
Intervention: Cefazolin (CFZ)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cefoperazone (CFP)
Number of subjects: 60
Study: 31213063

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy targeting emotion regulation
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Pre-treatment levels of child-reported emotion inhibition
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Pre-treatment levels of parent and child-reported emotion regulation
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Pre-treatment levels of behavioural and emotional symptom severity
Number of subjects: 48
Study: 27988219

Group type: EXPERIMENTAL
Intervention: Weight-loss intervention with calorie-restricted diets and exercise guidance (approximate weight loss of 0.91 kg/wk)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Increased red meat consumption
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Increased poultry intake
Number of subjects: 40
Study: 27400912

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 1031

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1031
Study: 24938224

Group type: EXPERIMENTAL
Intervention: Flaxseed (30 g of milled flaxseed per day for six months)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 100
Study: 22643948

Group type: EXPERIMENTAL
Intervention: Topical steroid drops applied with the Mygind technique for 8 weeks postoperatively
Number of subjects: 43

Group type: COMPARATOR
Intervention: Topical steroid sprays for 8 weeks postoperatively
Number of subjects: 43
Study: 20546812

Group type: EXPERIMENTAL
Intervention: Sucrose sweetened fruit drink (SSD)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Orange juice (OJ)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Semi-skimmed milk (M)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Calorie free (artificially sweetened) fruit drink (CTRL)
Number of subjects: 47
Study: 18640074

Group type: EXPERIMENTAL
Intervention: Flexible-dose pregabalin (150-600 mg/d)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Fixed-dose pregabalin (300 mg/d)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Flexible-dose pregabalin
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Fixed-dose pregabalin
Number of subjects: 269
Study: 16398377

Group type: EXPERIMENTAL
Intervention: Suntouch radiant warmer
Number of subjects: 60

Group type: COMPARATOR
Intervention: Forced-air warming
Number of subjects: 60
Study: 12766124

Group type: EXPERIMENTAL
Intervention: Zofenopril
Number of subjects: 303

Group type: COMPARATOR
Intervention: Nondiabetic patients
Number of subjects: 303

Group type: COMPARATOR
Intervention: Diabetic patients
Number of subjects: 303
Study: 10556869

Group type: EXPERIMENTAL
Intervention: 40/50 mg metrifonate
Number of subjects: 605

Group type: EXPERIMENTAL
Intervention: 60/80 mg metrifonate
Number of subjects: 605

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 605
Study: 8876303

Group type: EXPERIMENTAL
Intervention: 0.01% estradiol
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 0.3% estriol
Number of subjects: 59
Study: 1579337

Group type: EXPERIMENTAL
Intervention: 250 mg ticlopidine b.i.d. (49 patients)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (51 patients)
Number of subjects: 100
Study: 4073083

Group type: EXPERIMENTAL
Intervention: Ticarcillin plus clavulanic acid
Number of subjects: 85

Group type: COMPARATOR
Intervention: Gentamicin plus clindamycin
Number of subjects: 85
Study: 31879857

Group type: EXPERIMENTAL
Intervention: Increased fairness at the workplace (organizational justice)
Number of subjects: 7506

Group type: EXPERIMENTAL
Intervention: Decreased fairness at the workplace (organizational justice)
Number of subjects: 7506

Group type: EXPERIMENTAL
Intervention: Changes in organizational justice (distributive, procedural, interactional)
Number of subjects: 7506
Study: 29413242

Group type: EXPERIMENTAL
Intervention: Paclitaxel-Eluting Balloon (DEB)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Everolimus-Eluting Stent (DES)
Number of subjects: 278
Study: 27182847

Group type: EXPERIMENTAL
Intervention: Self-management occupational therapy intervention program (SMOoTh)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 31
Study: 25378913

Group type: EXPERIMENTAL
Intervention: Goal-Directed Fluid Therapy (GDFT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional intraoperative fluid management (Control)
Number of subjects: 60
Study: 23301466

Group type: EXPERIMENTAL
Intervention: Electroacupuncture + medication
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Conventional acupuncture + medication
Number of subjects: 102

Group type: COMPARATOR
Intervention: Medication (seroxat)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 102
Study: 20658791

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Desvenlafaxine
Number of subjects: 14
Study: 18215590

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 4600

Group type: EXPERIMENTAL
Intervention: Tranexamic Acid
Number of subjects: 4600

Group type: EXPERIMENTAL
Intervention: Both Aspirin and Tranexamic Acid
Number of subjects: 4600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4600
Study: 15825877

Group type: EXPERIMENTAL
Intervention: Noninvasive detection using arterio-oscillo-graphy
Number of subjects: 51
Study: 12730088

Group type: EXPERIMENTAL
Intervention: naproxen (1000 mg/d)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: aspirin (75 mg/d)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: diclofenac (150 mg/d)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: rofecoxib (50 mg/d)
Number of subjects: 45
Study: 12564001

Group type: EXPERIMENTAL
Intervention: Endoscopy group (20 eyes)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (10 eyes)
Number of subjects: 30
Study: 8764424

Group type: EXPERIMENTAL
Intervention: Radical mastectomy (mastectomy and formal axillary dissection with pectoral muscle excision)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Simple mastectomy (mastectomy without axillary dissection if nodes were not clinically palpable, or local excision of the nodes if they were)
Number of subjects: 95
Study: 1801542

Group type: EXPERIMENTAL
Intervention: deprenyl, 10 mg/day
Number of subjects: 800

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: alpha-tocopherol, 2,000 I.U./day
Number of subjects: 800
Study: 7047649

Group type: EXPERIMENTAL
Intervention: Gentamycin (single injection one hour before surgery)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Untreated group (no antibiotic)
Number of subjects: 47
Study: 30922997

Group type: EXPERIMENTAL
Intervention: Budesonide orodispersible tablet (BOT) 1 mg twice daily; n = 59
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo; n = 29
Number of subjects: 88
Study: 30646295

Group type: EXPERIMENTAL
Intervention: Early enrollment strategy using advance consent
Number of subjects: 52
Study: 26846607

Group type: COMPARATOR
Intervention: NSPT alone
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: NSPT + Nd:YAG laser therapy
Number of subjects: 87
Study: 24853958

Group type: EXPERIMENTAL
Intervention: Humerus interlocking nail (HIL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Locking compression plate (LCP)
Number of subjects: 40
Study: 22583135

Group type: EXPERIMENTAL
Intervention: Skin testing with various CM (iobitridol, iomeprol, iodixanol, iohexol, ioversol, iopramide, ioxaglate)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Drug provocation test (DPT)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Skin testing and DPT combined
Number of subjects: 161
Study: 20466427

Group type: EXPERIMENTAL
Intervention: Iris-fixated foldable posterior chamber IOL (PCIOL; AcrySof MA60AC)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Iris-claw anterior chamber IOL (ACIOL; Artisan)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Both groups (PCIOL and ACIOL)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Iris-fixated foldable posterior chamber IOL (PCIOL)
Number of subjects: 16
Study: 17177272

Group type: EXPERIMENTAL
Intervention: Macrophage colony-stimulating factor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interval estimator using tanh(−1)(x) transformation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomization-based interval estimator
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All interval estimators considered
Number of subjects: 0
Study: 16101620

Group type: EXPERIMENTAL
Intervention: Managed Ventricular Pacing (MVP)
Number of subjects: 181

Group type: COMPARATOR
Intervention: DDD/R
Number of subjects: 181
Study: 11908467

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg once daily for 8 weeks
Number of subjects: 4
Study: 10456811

Group type: EXPERIMENTAL
Intervention: Dopamine (2.5, 5.0, 7.5 microg kg(‐1) min(‐1))
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Metoclopramid (10 mg i.v. bolus during dopamine infusion)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Metoclopramid (10 mg i.v. bolus before dopamine infusion)
Number of subjects: 8
Study: 7615484

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Zolpidem 15 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Alcohol (0.08% peak blood alcohol concentration)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 2475056

Group type: EXPERIMENTAL
Intervention: Intramuscular therapy with vitamin D (600,000 IU)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Oral vitamin D
Number of subjects: 250
Study: 31915800

Group type: EXPERIMENTAL
Intervention: Cathodal tsDCS
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Anodal tsDCS
Number of subjects: 2

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 2
Study: 29161371

Group type: EXPERIMENTAL
Intervention: MI Paste Plus (MPP), applied once a day at bedtime for 12 months
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control paste, applied once a day at bedtime for 12 months
Number of subjects: 51
Study: 28159565

Group type: EXPERIMENTAL
Intervention: Single-Port (SP) sleeve gastrectomy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional Multiport Laparoscopy (LAP) sleeve gastrectomy
Number of subjects: 30
Study: 25154423

Group type: EXPERIMENTAL
Intervention: General Accepted Practices (GAPs) for HHD access care training by nurses
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: General Accepted Practices (GAPs) for HHD access care adherence
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Training on identification of signs and symptoms of infection
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Overall adherence to GAP
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Practices without GAPs
Number of subjects: 19
Study: 23302322

Group type: EXPERIMENTAL
Intervention: E-learning supported Train-the-Trainer program for guideline application, 1-day training, 60-minute e-learning module
Number of subjects: 936

Group type: COMPARATOR
Intervention: Traditional dissemination of the guideline (manuals, books, conferences, internet, reviews)
Number of subjects: 936
Study: 21266057

Group type: EXPERIMENTAL
Intervention: Bupropion (150 mg bid)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study: 19143855

Group type: EXPERIMENTAL
Intervention: Lumiracoxib 400 mg once daily (qd)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Naproxen 500 mg twice daily (bid)
Number of subjects: 406
Study: 17166990

Group type: EXPERIMENTAL
Intervention: SMART (budesonide/formoterol 80/4.5 microg qd maintenance plus additional inhalations for symptom relief)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Fixed-dose budesonide (320 microg qd)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Fixed-dose combination (budesonide/formoterol 80/4.5 microg qd)
Number of subjects: 341
Study: 14624410

Group type: EXPERIMENTAL
Intervention: Portfolio diet (n=13)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Low-saturated fat diet (n=12)
Number of subjects: 25
Study: 10809032

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg once daily intravenously followed by 500 mg once daily orally)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Cefuroxime plus erythromycin (750 mg every 8 hours intravenously followed by 500 mg twice daily orally for cefuroxime and 500-1000 mg every 6 hours for erythromycin)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Cefuroxime plus erythromycin
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 145
Study: 8892000

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 1426224

Group type: EXPERIMENTAL
Intervention: Nebulized lignocaine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sprayed lignocaine
Number of subjects: 54
Study: 3871477

Group type: EXPERIMENTAL
Intervention: Haemophilus influenzae type b capsular polysaccharide‐diphtheria toxoid conjugate vaccine (PRP‐D)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Haemophilus influenzae type b capsular polysaccharide vaccine (PRP)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PRP-D
Number of subjects: 60
Study: 31176532

Group type: EXPERIMENTAL
Intervention: Facial proportions from frontal photographs
Number of subjects: 800
Study: 29038966

Group type: EXPERIMENTAL
Intervention: Case Management with Community Health Worker Support (CM+CHW)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Case Management alone (CM)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 207
Study: 24612825

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Health-Enhancement Program (HEP)
Number of subjects: 0
Study: 23152592

Group type: EXPERIMENTAL
Intervention: Intranasal administration of oxytocin (OXT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 18651213

Group type: EXPERIMENTAL
Intervention: Male circumcision intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Scale to measure sexual risk behavior
Number of subjects: 0
Study: 18622797

Group type: EXPERIMENTAL
Intervention: Adjustable Pivotal cutting blocks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional fixed navigation cutting blocks
Number of subjects: 40
Study: 16259688

Group type: EXPERIMENTAL
Intervention: Regular sessions with a physiotherapist (intervention arm)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control arm (no information about physiotherapy sessions)
Number of subjects: 87
Study: 12127381

Group type: EXPERIMENTAL
Intervention: Maintenance of lightweight (BMI <15th percentile)
Number of subjects: 5098

Group type: EXPERIMENTAL
Intervention: Normal-weight children who became overweight
Number of subjects: 5098

Group type: EXPERIMENTAL
Intervention: Heavier children at age 11 years
Number of subjects: 5098

Group type: EXPERIMENTAL
Intervention: Lightweight at age 9 years
Number of subjects: 5098

Group type: EXPERIMENTAL
Intervention: CATCH children maintaining lightweight
Number of subjects: 5098

Group type: EXPERIMENTAL
Intervention: Normal-weight children who entered the overweight category
Number of subjects: 5098
Study: 10447791

Group type: EXPERIMENTAL
Intervention: Diet advice (D)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Exercise advice (E)
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Diet and exercise advice (DE)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 158
Study: 7755996

Group type: EXPERIMENTAL
Intervention: Multiplane probe
Number of subjects: 317

Group type: COMPARATOR
Intervention: Biplane probe
Number of subjects: 317